Namiki Izumi

Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C

Yasuhito Tanaka, Nao Nishida, Masaya Sugiyama et al. · Nature Genetics · 2009 · 2.1K citations

Genome-wide Association, Hepatology, Hepatitis C +14

Mutations in the Nonstructural Protein 5a Gene and Response to Interferon in Patients with Chronic Hepatitis C Virus 1b Infection

Nobuyuki Enomoto, Ikuo Sakuma, Yasuhiro Asahina et al. · New England Journal of Medicine · 1996 · 1K citations

Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version

Masatoshi Kudo, Namiki Izumi, Norihiro Kokudo et al. · Digestive Diseases · 2011 · 819 citations

Pathology, Cancer Death, Clinical Practice Guidelines +17

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial

Masatoshi Kudo, Kazuomi Ueshima, Masafumi Ikeda et al. · Gut · 2019 · 686 citations · Full text

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region.

Naoya Enomoto, Ikuo Sakuma, Yasuhiro Asahina et al. · Journal of Clinical Investigation · 1995 · 634 citations · Full text

Immunology, Pathology, Amino Acid Substitutions +20